Skip to main content

Peer Review reports

From: Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer

Original Submission
26 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
2 Aug 2023 Reviewed Reviewer Report
15 Sep 2023 Reviewed Reviewer Report
28 Oct 2023 Author responded Author comments - Liping Dai
Resubmission - Version 4
28 Oct 2023 Submitted Manuscript version 4
30 Oct 2023 Author responded Author comments - Liping Dai
Resubmission - Version 5
30 Oct 2023 Submitted Manuscript version 5
1 Nov 2023 Author responded Author comments - Liping Dai
Resubmission - Version 6
1 Nov 2023 Submitted Manuscript version 6
4 Nov 2023 Author responded Author comments - Liping Dai
Resubmission - Version 7
4 Nov 2023 Submitted Manuscript version 7
9 Nov 2023 Author responded Author comments - Liping Dai
Resubmission - Version 8
9 Nov 2023 Submitted Manuscript version 8
5 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
18 Feb 2024 Editorially accepted
2 Mar 2024 Article published 10.1186/s12885-024-12019-w

You can find further information about peer review here.

Back to article page